Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Adaptive Statistical Analysis and Continuous Inference Framework

Active

Federal

Response Deadline11/30/2026, 10:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

NAICS

541690 - Other Scientific and Technical Consulting Services

Place of Performance

DC

Set-Aside

NONE

Documents

This scope was carved out of ARPA-H-SOL-26-164.

The full solicitation package (3 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedSep 30

subcontract

Response DeadlineNov 30

Submission deadline

Response Deadline

11/30/2026, 10:00:00 PM UTCin about 2 months

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

ContactsNo contacts available

OfficeN/A

Organization / AgencyDepartment Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Performs development of validated statistical and regulatory frameworks for continuous inference for prime contractors on ARPA-H projects. Implements adaptive elements including futility, efficacy, and safety stopping rules, sample size re-estimation, and response-adaptive randomization. Aligns with FDA/CBER/CDER standards for adaptive trials. Delivers a validated statistical framework and adaptive decision rules.

Similar Contracts

Same NAICS industry code

Healthcare Data Security and Privacy Compliance

Roswell Park Cancer Institute Corporation

POSTED

about 20 hours ago

DEADLINE

Program Evaluation & Data Reporting

OHA Behavioral Health

POSTED

about 23 hours ago

DEADLINE

Evaluation of Thermal Energy Efficiency Programs in Vermont’s Single Family Residential Existing Buildings Market

Solicitation # 76193

The Vermont Department of Public Service is seeking a contractor or team of contractors to evaluate energy efficiency retrofit programs for the single-family existing buildings market in Vermont. The scope of work involves assessing both thermal and electrical energy savings across three primary tracks: the VGS Residential Retrofit program, the VGS low-income home retrofit program implemented with the Champlain Valley Weatherization Service, and the statewide Home Performance with ENERGY STAR program. The selected contractor will perform impact evaluations to provide independent savings estimates and process evaluations to recommend improvements for participation rates and administrative costs. The project has a total budget not to exceed 300,000 dollars, with an additional 50,000 dollars potentially available for technical assistance. The expected contract period is 14 months, with a work schedule of 10 months and a final completion date of September 30, 2027. Key deliverables include a final process evaluation report due April 2, 2027, and final impact evaluation reports due May 28, 2027. Proposals will be evaluated based on the proposed approach, the experience of the bidding firm and key personnel, and the quality of the presentation. Contractors must be prepared to begin work immediately upon award and must sign confidentiality agreements to protect consumer billing and customer data.

Department of Economic Development

POSTED

DEADLINE

in about 1 month

Accessibility Compliance & PDF Remediation

Orlando Housing Authority

POSTED

DEADLINE

in about 1 month

Safety Data Environmental Scan & Analysis

693KA9 Contracting For Services

POSTED

DEADLINE

in about 1 month

AI Governance, Risk, and Compliance (GRC)

Information Technology Division

POSTED

DEADLINE

Waller County Mobility Plan

Solicitation # RFP-TRN26-14

The Houston-Galveston Area Council (H-GAC) is soliciting proposals under RFP-TRN26-14 for the development of a comprehensive Waller County Mobility Plan. This total fixed-price planning study, with a maximum budget of 700,000 USD in federal funding, serves as an update to the 2019 Waller County Transportation Plan to address rapid population growth and improve safety, access, and mobility. The scope of work is strictly limited to planning and does not include engineering design services or stamped drawings. Key deliverables include a Project Management Plan with QA/QC procedures, a Public Involvement Plan due within 45 days of execution, a minimum of three steering committee meetings, two rounds of stakeholder and public meetings, and a data analysis workshop. The selection process is managed by an evaluation committee using a weighted scoring system, with final award approval granted by the H-GAC Board of Directors. Successful respondents must maintain active SAM registration and comply with various federal and state mandates, including Buy America provisions, Equal Employment Opportunity standards, and Texas Government Code requirements regarding cybersecurity training and interested party disclosures. Contract administration involves monthly progress reporting and payments issued via electronic ACH on Net 30 terms. Proposals must be submitted electronically via the OpenGov portal by November 12, 2026, and must include a detailed project schedule and a Challenge, Opportunity, and Success Statement.

POSTED

DEADLINE

in about 1 month

Third-Party Risk Management (TPRM) Services

Nassau Community College

POSTED

DEADLINE

GRC and Risk Management Services

Nassau Community College

POSTED

DEADLINE

GRC Framework & Content Specialist

POSTED

DEADLINE

Data Analysis & Performance Metrics Support

Federal Highway Administration

POSTED

DEADLINE

Pre-RFP Engagement: Vegetation Consulting Services

Solicitation # NTV-00025063

The British Columbia Hydro and Power Authority has issued a pre-solicitation notice, NTV-00025063, for upcoming Vegetation Consulting Services to support forestry-related capital projects and vegetation management programs across British Columbia. The scope of work is divided into distribution and transmission consulting services, encompassing tasks such as vegetation assessment, work layout, right-of-way recovery, maintenance consulting, access planning, and stakeholder communication. These services will be provided on an as-needed basis. The anticipated contract structure includes an initial term of five years with the possibility of extensions for up to an additional five years, totaling a potential ten-year duration. Interested parties must meet specific safety and technical requirements, including compliance with WorkSafeBC standards and registration with Alcumus SafeContractor. Contractors are expected to provide proof of insurance, a quality management process, and possess technical equipment such as laptops, GPS, and mobile devices capable of running the Esri Field Maps app. While this notice serves as early market notification and not a formal solicitation, the Request for Proposal was anticipated for release in mid-October 2026, with a response deadline of November 10, 2026. All final procurement documents and submissions are managed through the BC Bid portal.

British Columbia Hydro and Power Authority

POSTED

DEADLINE

in about 1 month

More opportunities from Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

Same awarding agency

Agentic Clinical Operations and AI Automation Systems

Computer Systems Design Services

POSTED

DEADLINE

in about 2 months

Clinical Trial Simulation and In Silico Design Services

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

in about 2 months

Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)

Solicitation # ARPA-H-SOL-26-164

The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals for the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program under solicitation ARPA-H-SOL-26-164. This five-year initiative aims to create a reusable blueprint for future adaptive seamless platform trials through the integration of three technical areas: a Phaseless Design Engine, Continuous Inference, and Agentic Operations. The program is divided into two stages, with Stage I focusing on capability buildout, FDA engagement, and the onboarding of at least three intervention arms over 24 months, followed by a 36-month Stage II dedicated to validation and deployment. A critical go/no-go milestone is obtaining FDA authorization for the platform Master Protocol IND and at least one investigational arm by the end of Stage I. The government intends to make multiple awards via Other Transaction Agreements to proposers offering the most advantageous solutions based on innovation, feasibility, and technical merit at reasonable prices. Eligible entities must possess a Unique Entity Identifier and active SAM registration. Proposals are submitted in a phased approach, beginning with a Solution Summary and potentially progressing to a Solution Pitch package. Performance will be measured by the successful integration of the three technical areas and the achievement of specific program metrics. All work must adhere to ICH E6(R3) Good Clinical Practice and strict regulatory standards to ensure inspection readiness and participant safety.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

in about 2 months

SURPASS Webinar and Proposers' Day Information

Solicitation # ARPA-H-SN-26-164

The Advanced Research Projects Agency for Health (ARPA-H), under the Department of Health and Human Services, has issued Special Notice ARPA-H-SN-26-164 regarding the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program. This initiative aims to modernize clinical research by transforming drug and biologics development into a continuous learning system, with the goal of reducing development timelines from over ten years to fewer than four. The program focuses on creating disease-specific multi-arm platforms that integrate AI-powered operational infrastructure, in silico modeling, and advanced adaptive designs to enable a seamless transition from first-in-patient evaluation to confirmatory assessment. Key outputs include a reusable blueprint for future trials, simulation-based design tools, and continuous inference and adaptation approaches, all aligning with the goals of HHS Operation TrialBlazer. This specific notice serves as an informational announcement and does not constitute a formal solicitation for proposals. It invites interested parties to an informational webinar on October 15, 2026, and a two-day Proposers Day on November 6 and 9, 2026. Potential participants may optionally submit teaming profiles, lightning talk slides, and posters to showcase their expertise. Full program details and formal solicitation requirements are located under solicitation ARPA-H-SOL-26-164. All inquiries are directed to the SURPASS team, with Daria Fedyukina serving as the Technical Point of Contact.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

ARPA-H Comprehensive Organ System Modeling in Outer Space (COSMOS) Innovative Solutions Opening

Solicitation # ARPA-H-SOL-26-165

The Advanced Research Projects Agency for Health (ARPA-H) is seeking proposals under solicitation ARPA-H-SOL-26-165 for the Comprehensive Organ System Modeling in Outer Space (COSMOS) initiative. This program aims to determine if microgravity in Low Earth Orbit (LEO) accelerates tissue aging across brain, cardiac, uterine, and kidney tissues compared to terrestrial rates. If the Tissue Aging Rate in Space (TARIS) is found to significantly exceed the Tissue Aging Rate on Earth (TAROE), the initiative intends to establish a high-throughput, autonomous drug screening platform in LEO to make biomedical research and development more cost-effective and faster than Earth-based methods. The project is structured into two sequential phases: a 27-month Phase I focused on establishing and validating microphysiological systems (MPS) to quantify aging rates, and a 15-month Phase II dedicated to developing age-related pathology models for pro-regenerative drug testing. Key requirements include the use of MPS or organoids for at least 75 percent of experimental samples, the creation of LEO twin experiments, and the establishment of a contractual partnership with at least one Fortune 100 biopharmaceutical company. The program schedule spans FY27 through FY30 and includes two planned space launches in months 39 and 41. Awards will be granted via multiple Other Transaction (OT) Agreements to the most advantageous proposers, including universities, non-profits, and businesses. Evaluation is based primarily on the innovation and feasibility of the technical approach, the potential to transform biomedicine, and the team's expertise in managing costs and schedules. Proposers must adhere to strict administrative requirements, including the BIOSECURE Act, NIH Genomic Data Sharing policies, and specific research security and cybersecurity disclosures. Full proposals are due by October 7, 2026.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

ARPA-H Emerging Health Innovators (EHI) Initiative

Solicitation # ARPA-H-SOL-26-150

The Advanced Research Projects Agency for Health (ARPA-H) Emerging Health Innovators (EHI) initiative, solicitation ARPA-H-SOL-26-150, is a mentorship program designed to identify and engage early-career investigators for cutting-edge biomedical, health, and community-engaged research. Eligible principal investigators must be within eight years of completing their first terminal degree. The program focuses on 16 specific topic areas and utilizes a two-step submission process, beginning with an anonymized solution summary due October 30, 2026, followed by full proposals due February 10, 2027. Awards are issued as Other Transaction (OT) agreements with a tentative start date of June 30, 2027. Each award has a total value not to exceed 1,050,000 dollars over a three-year period, consisting of a two-year base period capped at 700,000 dollars and an optional third year capped at 350,000 dollars. Funding is structured around a fixed-price milestone payment schedule, with 12 total quarterly milestones and payments processed through the Payment Management Services (PMS) system. Performance is monitored via monthly one-hour virtual reviews with the ARPA-H program team. Evaluation is based on technical merit, innovativeness, feasibility, and alignment with the ARPA-H mission, with a strong emphasis on risk mitigation and the potential to impact national health research.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening (ISO)

Solicitation # ARPA-H-SOL-26-162

The Advanced Research Projects Agency for Health (ARPA-H) has issued Innovative Solutions Opening (ISO) ARPA-H-SOL-26-162 for the UNifying Imaging with QUantum Entanglement (UNIQUE) program. This 18-month, two-phase initiative seeks to develop a new biomedical imaging paradigm by integrating anatomical, functional, and molecular data with quantum-derived observables and entangled 511 keV photon pairs. The scope is divided into two technical areas: TA1, which focuses on the physical systems required to generate and measure quantum observables in biomedical settings, and TA2, which focuses on the computational foundation, including AI-driven reconstruction and multimodal data fusion. ARPA-H anticipates awarding multiple Other Transaction (OT) Agreements to eligible entities, including universities, non-profit organizations, and businesses. For-profit organizations that exceed the NAICS 541714 SBA size standard of 1,000 employees are required to provide a meaningful cost share. The application process follows a two-stage submission cycle, with Solution Summaries due by late October 2026 and Full Proposals due by December 15, 2026, with a final response deadline of December 16, 2026. Full proposals must consist of three volumes covering technical and management plans, cost proposals, and administrative requirements. Evaluation is based on the innovation and feasibility of the technical approach, the expertise of the personnel, the potential to transform biomedicine, and cost reasonableness. Key requirements include compliance with HHS regulations on human stem cells, adherence to cybersecurity standards, and restrictions on gain-of-function research and funding for foreign entities in countries of concern. Awardees will be expected to provide monthly status reports and participate in semi-annual in-person PI review meetings.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

UNifying Imaging with QUantum Entanglement (UNIQUE) Proposers' Day

Solicitation # ARPA-H-SN-26-162

The Advanced Research Projects Agency for Health (ARPA-H), through its Health Science Futures Office, has issued Special Notice ARPA-H-SN-26-162 to announce the UNifying Imaging with QUantum Entanglement (UNIQUE) program. This initiative aims to establish a new biomedical imaging paradigm by utilizing quantum-derived observables, specifically entangled or quantum-correlated 511 keV photon pairs, to reveal disease biology that is currently invisible to existing imaging technologies. The program is divided into two technical areas: an Imaging Core focused on physical systems and quantum-aware detectors, and a second area focused on AI-driven reconstruction and fusion methods to integrate anatomical, functional, molecular, and quantum-derived information. To support this effort, a hybrid Proposers Day is scheduled for October 16, 2026, at 8:30am ET, held at the Executive Conference Center in Arlington, Virginia. This event is designed to provide technical details, promote teaming, and alert the scientific community to an upcoming Innovative Solutions Opening (ISO) that was scheduled for release by September 18, 2026. Interested parties are encouraged to use the provided Lightning Talk Template to showcase their capabilities and teaming goals. While this notice provides program goals and technical direction, it is issued for information and planning purposes and does not constitute a formal solicitation for proposals. The primary point of contact for the program is Program Manager Wilfred Ngwa.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Restorative and health-Enhancing Sleep Time (REST)

Solicitation # ARPA-H-SOL-26-159

The Advanced Research Projects Agency for Health (ARPA-H) Proactive Health Office has issued solicitation ARPA-H-SOL-26-159 for the Restorative and health-Enhancing Sleep Time (REST) program. This initiative aims to transform the measurement and treatment of poor sleep, specifically insomnia, by developing objective, home-based, closed-loop technologies. The program focuses on detecting and responding to sleep microstructures in real time to improve long-term health outcomes, moving away from traditional macrostructure measures like sleep duration. The scope is divided into two technical areas: Measure and Diagnose (TA1), which focuses on in-home diagnostic systems using objective physiological signals, and Control and Treat (TA2), which focuses on noninvasive, adaptive intervention systems. The program is structured as a 66-month effort spanning three phases: proving the core technical thesis, demonstrating a proof-of-concept, and achieving clinical translation and commercialization. Awards will be granted via Other Transaction (OT) instruments, with payments tied to a quarterly milestone schedule. Evaluation is based on scientific merit, feasibility, innovation, and proposer capabilities, with specific success metrics tied to Polysomnography (PSG) fidelity and diagnostic accuracy. Proposers must submit a Solution Summary by August 12, 2026, and selected candidates will proceed to a full proposal process involving a technical pitch and detailed documentation. The final proposal deadline is October 13, 2026. Requirements include active SAM.gov registration, Institutional Review Board (IRB) approval for human subjects research, and a comprehensive FDA regulatory strategy.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Independent Verification and Validation (IV&V) ServicesThis subcontract for Independent Verification and Validation (IV&V) Services supports the Advanced Research Projects Agency for Health (ARPA-H) within the Department of Health and Human Services. The selected provider will perform independent evaluations of technical milestones and safety metrics for prime contractors on SPECTRA projects, specifically focusing on reviewing adverse event safety data, validating functional performance gains, and auditing federated network cross-query functionality. The role requires independent safety monitor certification to deliver critical IV&V reports and safety validation certifications. This opportunity was posted on September 17, 2026, with a response deadline of October 18, 2026, falling under NAICS code 541690.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Embedded Assessment and Communication Technology DevelopmentThis subcontract for the Advanced Research Projects Agency for Health (ARPA-H) focuses on the development of embedded assessment and communication technology to support prime contractors on SPECTRA projects. The primary objective is to create real-world measurement tools and assistive technologies, including telemetry ingestion for common schemas and LLM-based atypical speech recognition to enhance communication throughput and identify adverse events. The project requires the delivery of validated measures and functional support devices while maintaining strict safety monitoring for medical devices and privacy protections for data collected from home environments. This opportunity was posted on September 17, 2026, with a response deadline of October 18, 2026, under NAICS code 517919.

All Other Telecommunications

POSTED

DEADLINE

Precision Intervention and Trajectory TestingThe Precision Intervention and Trajectory Testing subcontract, issued by the Advanced Research Projects Agency for Health under the Department of Health and Human Services, focuses on conducting clinical trials to test interventions for prime contractors on ARPA-H SPECTRA projects. The scope of work involves running stratified trials based on participant identification and testing intervention mechanisms against trajectory-driven harms while utilizing routine care endpoint data to validate the effectiveness of precision interventions. To qualify for this engagement, providers must obtain IRB approval and maintain Good Clinical Practice certification. The opportunity was posted on September 17, 2026, with a response deadline of October 18, 2026, and is categorized under NAICS code 541715.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS